US Patent Issued to Morningside Venture Investments on June 9 for "Optimized bio-synchronous bioactive agent delivery system" (California, Washington Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,029, issued on June 9, was assigned to Morningside Venture Investments Ltd. (Newton Centre, Mass.).

"Optimized bio-synchronous bioactive agent delivery system" was invented by Guy DiPierro (San Francisco) and Alan Joel Levy (Bellevue, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Optimized bio-synchronous drug delivery begins with establishing a bio-synchronous treatment protocol that incorporates individual temporal and innate biological characteristics into a pharmacological treatment plan. The bio-synchronous treatment protocol is thereafter initiated using bioactive agent delivery device. Bio-synchronous drug delivery includes continual co...